David P Meeker's Net Worth

$15.3 Million

Estimate Recalculated Nov 11, 2024 08:40AM EST

Who is David P Meeker?

David P Meeker has an estimated net worth of $15.3 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., GENZYME CORP, SAVIENT PHARMACEUTICALS INC, MyoKardia Inc, Trevi Therapeutics, Inc., TURMERIC ACQUISITION CORP., and PENWEST PHARMACEUTICALS CO.

SEC CIK

David P Meeker's CIK is 0001385155

Past Insider Trading and Trends

2020 was David P Meeker's most active year for acquiring shares with 8 total transactions. David P Meeker's most active month to acquire stocks was the month of May. 2011 was David P Meeker's most active year for disposing of shares, totalling 18 transactions. David P Meeker's most active month to dispose stocks was the month of March. 2010 saw David P Meeker paying a total of $3,547,132.72 for 96,929 shares, this is the most they've acquired in one year. In 2011 David P Meeker cashed out on 476,761 shares for a total of $24,809,604.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.67%
-45.49K
$39.22
-$1,784,274.68
174.6K
Mar 19
Form 4
+81.75%
99K
—
—
220.1K
Feb 16
Form 4
+8.77%
9.76K
$45.06
-$196,506.66
121.1K
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 9
Form 4
+9.87%
10K
$20.17
$201,713.00
111.33K
Mar 30
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
0
Jul 20
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 6
Form 4
+364.63%
79.53K
$17.00
—
101.33K
Oct 10
Form 3
—
0
—
—
0
No matching records found

GENZYME CORP No price found

ExecVP,Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-11.88K
$74.00
-$3,043,398.00
0
Apr 4
Form 4
—
0
—
—
0
Jun 16
Form 4
+114.00%
5.35K
$45.60
-$124,579.20
10.04K
May 24 - May 25
Form 4
—
0
$37.78
-$371,969.28
4.69K
Scheduled
May 21
Form 4
—
0
—
—
0
May 21
Form 4
+89.81%
2K
$51.95
$103,906.40
4.23K
Apr 23
Form 4
—
0
$51.89
-$1,113,654.00
1.89K
Aug 15
Form 4
—
0
—
—
0
May 22
Form 3
—
0
—
—
0
No matching records found

SAVIENT PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
12.64K
$1.17
$14,793.48
12.64K
Jan 7
Form 3
—
0
—
—
0
No matching records found

MyoKardia Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.10K
—
—
0
Nov 17
Form 4/A
∞
2.3K
—
—
2.3K
Jun 13
Form 4
—
0
—
—
0
Jun 18
Form 4
∞
2.3K
—
—
2.3K
Jun 13
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Apr 17
Form 3
—
0
—
—
0
No matching records found

Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$2.18
-$6,838.88
352.49K
Aug 27
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 28
Form 4/A
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 11
Form 4
+36.35%
352.49K
$10.00
$112,500.00
1.32M
May 9
Form 4
—
0
—
—
0
May 7
Form 3
—
0
—
—
0
No matching records found